Santa Rosa, California (May 24, 2012) — In a groundbreaking study, Modified Citrus Pectin (MCP), a highly researched natural compound enhanced the anti-cancer effects of two poly-botanical formulas. When co-administered with formulas that attack breast and prostate cancer, MCP significantly increased their anti-cancer action, further reducing metastasis in highly invasive breast and prostate cancer cells. The study was led by researchers at the Cancer Research Laboratory at Indiana University Health and Indiana University School of Medicine, and published in the peer review journal Integrative Cancer Therapies. (more…)
“Our results are very exciting because we clearly demonstrate the suppression of breast to lung cancer metastasis associated with the inhibition of specific pro-metastatic genes in human tumors,” says Daniel Sliva, Ph.D., Associate Professor at the Indiana University School of Medicine and lead author on the study. (more…)
Santa Rosa, Calif. (March 26, 2012) — A non-toxic, botanical formula controls aggressive human prostate tumors in mice, according to a peer-reviewed study in the The International Journal of Oncology. Researchers at Indiana University, Methodist Research Institute, showed the prostate formula significantly suppresses tumor growth in aggressive, hormone-refractory (androgen-independent) human prostate cancer cells. The study also demonstrated the formula has no toxic side effects, even at high dosages. (more…)
Sonoma County, Calif. (March 20, 2012) — Calmly meditating produces exciting, beneficial effects on your body. It can protect your DNA against cancer-promoting genetic developments and free you from everyday stresses and distractions. That’s why meditation is one of the most powerful, but often neglected, tools for maintaining optimal health. (more…)
Carefree, Ariz. (March 8, 2012) — Galectin-3 sounds like a planet out of “Star Trek,” but it can be much more ominous. Recently, distinguished integrative physician Isaac Eliaz, M.D., presented breakthrough research demonstrating that the protein Galectin-3 is an active biomarker for numerous life-threatening diseases. Even more importantly, Dr. Eliaz showed how Modified Citrus Pectin (MCP) binds and blocks Galectin-3 throughout the body. The unique ability to inhibit and block the harmful effects of Galectin-3 is one of MCP’s many essential health benefits. (more…)
Carefree, Ariz., (March 6, 2012) — Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and researcher, presented Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases. He also shared new research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker. Dr. Eliaz’s latest presentation was given to hundreds of integrative oncologists during the Oncology Association of Naturopathic Physicians‘ 2012 Convention (OncANP).
OncANP is one of the largest naturopathic organizations with members who specialize in the treatment of cancer. A major focus of the association’s mission is to provide advanced training in the practice of naturopathic oncology for its membership and by doing so to improve the quality of care and patient outcome. (more…)
SANTA ROSA, Calif. — Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor model, appear online in The International Journal of Oncology. This is the third published study from a major university to show significant results of this specific multi-nutrient prostate formula against the invasive behavior of aggressive prostate cancer cells, tumor growth and metastasis. The formula combines botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms and antioxidants. (more…)
Dr. Isaac Eliaz Presents Galectin-3 as a Breakthrough Biomarker at the World’s Largest Anti-Aging Medical Conference
Las Vegas, Nevada (December 13, 2011)— Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and leading Modified Citrus Pectin expert, gives a keynote presentation on Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases. He also shared new research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker. Dr. Eliaz’s latest presentation was given to more than 1000 physicians, health practitioners, and scientists during the 19th Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies (A4M). Taking place December 8th-10th, the A4M conference features over 80 world renowned experts who present key clinical findings in human aging intervention.“It’s always a thrill to share cutting edge research with the medical community, demonstrating Modified Citrus Pectin’s ability to promote health and prevent disease,” says Dr. Eliaz. “MCP offers unprecedented health benefits by binding and blocking excess Galectin-3 molecules throughout the body. With the latest research linking Galectin-3 to the progression of numerous diseases, this presentation felt like a breakthrough moment where a new tool in medicine is being introduced to a whole medical community for the first time.” (more…)
Ontario, Canada (November 21, 2011) —Isaac Eliaz, M.D., M.S., L.Ac., world-renowned medical doctor, offers a presentation on the critical role of Modified Citrus Pectin (MCP) and Polybotanicals in Integrative Cancer Breakthroughs. The lecture was offered at The Ontario Association of Naturopathic Doctors (OAND) Conference, November 18th-20th, in Ontario, Canada. OAND is a professional association representing more than 60 percent of Ontario’s Naturopathic Doctors. The conference brings together hundreds of Naturopathic physicians, medical professionals and researchers to share the latest advancements in the treatment and prevention of disease. Dr. Eliaz says, “The most important message I’m sharing during my presentation is the value of true integration, mind-body medicine, and the exciting new research on Modified Citrus Pectin and one of its targets, Galectin-3.” (more…)
Cleveland, Ohio (November 16, 2011) – Isaac Eliaz, M.D., L.Ac., M.S., renowned medical doctor, presents a new breakthrough on Modified Citrus Pectin (MCP) and the role of Galectin-3 in health & disease. The poster presentation was shared during the 8th International Conference of the Society for Integrative Oncology, held November 9th-12th in Cleveland, OH. The conference brings together hundreds of top clinicians, researchers, patients and advocates to learn about new findings from diverse scientific disciplines that have the potential to transform cancer care. The theme of this year’s meeting is “Innovating Integrative Oncology: New Science, New Solutions; The Focus is the Patient.” More than 80 abstracts are presented, including Dr. Eliaz’s research on MCP and Galactin-3.
Over the last decade, a large body of peer-reviewed research has revealed that many serious health concerns are associated with elevated levels of Galectin-3 molecules. Modified Citrus Pectin – derived from citrus peels – is the only proven natural Galectin-3 inhibitor to address elevated Galectin-3 for cancer, metastasis and other chronic illnesses. (more…)